GlassScriptPhysician profile
Scott Lawrence Firestein
NPI 1407802465
$1,166.14
in general payments reported to CMS, 2019-2025
21 companies · $91.84 in 2025
The $91.84 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $38.05 · 2021: $221 · 2022: $250 · 2023: $193 · 2024: $58.57 · 2025: $91.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $264.54 | 2021-2025 | Acessa Provu System, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Gynesonics, INC. | $203.04 | 2022 | |
| Abbvie INC. | $169.69 | 2019-2023 | |
| Exact Sciences Corporation | $142.53 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $67.06 | 2023-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $41.68 | 2019-2020 | |
| Therapeuticsmd, INC. | $34.20 | 2019 | |
| Astellas Pharma US INC | $29.33 | 2019-2023 | Myrbetriq |
| Mayne Pharma Commercial LLC | $24.56 | 2023 | |
| Amarin Pharma, INC. | $20.91 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.61 | 2022 | |
| Neos Therapeutics, LP | $16.08 | 2023 | Adzenys Xr-Odt |
| Bayer Healthcare Pharmaceuticals INC. | $15.83 | 2023 | |
| Roche Diagnostics Corporation | $15.49 | 2019 | |
| Baxter Healthcare | $15.41 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $14.42 | 2019 | |
| Sage Therapeutics, LLC | $14.33 | 2019 | |
| Lupin INC. | $14.27 | 2019 | |
| Exeltis, USA INC. | $14.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.13 | 2022 | |
| Allergan, INC. | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Firestein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.